Global Stem Cells Group will attend the world-class GTCbio conference at the Hyatt Regency Boston Hotel, April 27-29. The event will showcase the latest developments in all areas of regenerative medicine, stem cell research and business.

Global Stem Cells Group has announced plans to attend the GTCbio Stem Cell Summit 2015 April 27 – 29, 2015 in Boston. This world-class summit will present the latest developments in all areas of stem cell research including applications, biology, medicine, regulations, and the business of stem cells and regenerative medicine.

The conference will address recent developments in pre-clinical and clinical trials, as well as translational research in stem cell therapies, regenerative medicine, tissue engineering, stem cell reprogramming and regulatory guidance. There will be an additional focus on business opportunities in stem cell medicine and its challenges, and discussions on potential strategies for overcoming these challenges.

The GTCbio Summit includes two parallel conferences with joint sessions on stem cell research in the diabetes space, and stem cell therapies from bench to bedside. Both conferences will also feature a lineup of 34 distinguished speakers from a broad spectrum in the medical community. Keynote speakers for both conferences include Masayo Takahashi, MD, PhD, CDB Ophthalmologist, Center for Developmental Biology; Douglas Melton, PhD, Professor & Investigator, Harvard Medical School, and Rudolf Jaenisch, MD, Professor of Biology, Massachusetts Institute of Technology.

Conference A: The 12th Stem Cell Research & Regenerative Medicine Conference discussion topics include:
Cells for Therapeutic Development & Drug Discovery
Advances in Adult & Pluripotent Stem Cells
Tissue Engineering
Immunotherapy: Revolution in Cancer Treatments
Joint Session: Regulatory Challenges in Cell Therapy

Conference B: The 4th Stem Cell Product Development & Commercialization Conference discussion topics include:
Manufacturing & Product Development
Challenges in Developing Clinical Efficacy
Funding Opportunities
Commercialization: Creating Sustainable Business Models
Joint Session: Regulatory Challenges in Cell Therapy

The GTCbio Summit 2015 will be held at the Hyatt Regency Boston Hotel. For more information, visit the summit website. To learn more about Global Stem Cells Group, visit the GSCG website, email bnovas(at)stemcellsgroup(dot)com, or call 305-560-5337. Global Stem Cells Group is a publicly traded company operating under the symbol MSSV.
Read More at: Official PR Release

Previous Post
Global Stem Cells Group Signs Consortia Innovas, SA to Exclusive Representative Contract for Chile Territory
Next Post
The different types of stem cells and their current uses

Latest posts